Top View
- 1 510(K) SUBSTANTIAL EQUIVALENCE DETERMINATION
- Fully Automated Platform for Determination of Tricyclic Antidepressant in Serum
- Silenor) National Drug Monograph September 2014 VA Pharmacy Benefits Management Services, Medical Advisory Panel, and VISN Pharmacist Executives
- Utah Medicaid Pharmacy & Therapeutics Drug Class Review
- Therapeutic and Toxic Blood Concentrations of More Than 1100 Drugs and Other Xenobiotics
- Toxicology Solutions
- Table [1]: Definition of Reported Outcomes Study Outcome
- Supplementary Table S1. the Tested Pgx Panel in the IP3 Pilot Study
- Antidepressants | V1 | 10/20
- 2007515 Tricyclic Antidepressants Quantitative
- Tricyclic Antidepressants Found in Pilots Fatally Injured in Civil Aviation Accidents
- Offline and Online Sample Extraction for the Quantification of Tricyclic Antidepressants in Human Plasma Or Serum for Clinical Research
- TRICYCLIC ANTIDEPRESSANTS in SERUM And/Or in PLASMA by UV CODE Z56010 ( Nordoxepin, Desipramine, Imipramine (TAD1), Doxepin, Amitriptyline and Nortriptyline (TAD2) )
- 022036Orig1s000
- Capillary Electrophoresis Screening Method for Six Tri- Cyclic Antidepressants in Human Serum
- TRICYCLIC ANTIDEPRESSANTS in SERUM And/Or in PLASMA by UV CODE Z56010 ( Nordoxepin, Desipramine, Imipramine (TAD1), Doxepin, Amitriptyline and Nortriptyline (TAD2) )
- Toxicology Approved By
- Therapeutic and Toxic Blood Concentrations of More Than 800 Drugs and Other Xenobiotics
- Metabolic N-Dealkylation and N-Oxidation As Elucidators of the Role of Alkylamino Moieties in Drugs Acting at Various Receptors
- Method Validation of a Tricyclic Antidepressant Drug Panel in Urine by UPLC-MS/MS